X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2802) 2802
Publication (364) 364
Book Chapter (24) 24
Book Review (11) 11
Dissertation (7) 7
Conference Proceeding (2) 2
Data Set (2) 2
Newspaper Article (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1781) 1781
index medicus (1294) 1294
cd38 (1056) 1056
cd38 expression (921) 921
male (897) 897
female (871) 871
hematology (824) 824
middle aged (711) 711
cd38 antigen (698) 698
adult (644) 644
oncology (626) 626
flow cytometry (584) 584
aged (567) 567
prognosis (557) 557
immunology (516) 516
animals (448) 448
leukemia, lymphocytic, chronic, b-cell - genetics (440) 440
expression (399) 399
chronic lymphocytic leukemia (389) 389
survival (355) 355
disease progression (342) 342
lymphocytes (341) 341
aged, 80 and over (336) 336
activation (316) 316
leukemia, lymphocytic, chronic, b-cell - pathology (310) 310
mice (300) 300
adp-ribosyl cyclase 1 (292) 292
apoptosis (291) 291
adp-ribosyl cyclase (288) 288
cancer (283) 283
cell biology (281) 281
cll (280) 280
membrane glycoproteins (268) 268
adp-ribosyl cyclase 1 - metabolism (261) 261
lymphocytes t (255) 255
leukemia (251) 251
cyclic adp-ribose (250) 250
analysis (246) 246
medicine (242) 242
mutation (241) 241
zap-70 expression (239) 239
gene expression (237) 237
genomic aberrations (237) 237
biochemistry & molecular biology (232) 232
leukemia, lymphocytic, chronic, b-cell - diagnosis (229) 229
cells (227) 227
disease (213) 213
immunophenotyping (206) 206
patients (203) 203
research (203) 203
leukemia, lymphocytic, chronic, b-cell - immunology (200) 200
research article (199) 199
t cells (197) 197
leukemia, lymphocytic, chronic, b-cell - metabolism (196) 196
b-cells (195) 195
multidisciplinary sciences (194) 194
variable-region mutations (194) 194
hemic and lymphatic diseases (192) 192
hiv infections - immunology (188) 188
pathology (186) 186
chronic lymphocytic-leukemia (185) 185
signal transduction (185) 185
hiv (182) 182
science (181) 181
immunoglobulin heavy chains - genetics (177) 177
infectious diseases (173) 173
cd4 antigen (171) 171
cell activation (170) 170
zap-70 (170) 170
leukemia, lymphocytic, chronic, b-cell - mortality (169) 169
differentiation (167) 167
cells, cultured (166) 166
health aspects (166) 166
adp-ribosyl cyclase 1 - genetics (165) 165
cytokines (163) 163
immunoglobulin variable region - genetics (163) 163
antigens, cd (160) 160
gene mutation status (160) 160
lymphocytes b (159) 159
multiple myeloma (158) 158
diagnosis (156) 156
genetic aspects (153) 153
proteins (153) 153
stem cells (150) 150
cd8 antigen (149) 149
antigens (148) 148
phenotype (148) 148
medicine, research & experimental (147) 147
care and treatment (146) 146
therapy (145) 145
histocompatibility antigen hla (143) 143
article (142) 142
bone marrow (142) 142
inflammation (142) 142
mutation status (141) 141
t-cells (140) 140
immune activation (137) 137
human immunodeficiency virus--hiv (134) 134
immunoglobulins (134) 134
nad (130) 130
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2788) 2788
French (9) 9
Russian (7) 7
Spanish (7) 7
Chinese (5) 5
German (3) 3
Korean (2) 2
Polish (2) 2
Persian (1) 1
Portuguese (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Neoplasia, ISSN 1476-5586, 06/2018, Volume 20, Issue 6, pp. 632 - 642
Journal Article
Blood, ISSN 0006-4971, 06/2003, Volume 101, Issue 12, pp. 4944 - 4951
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 09/2019, Volume 9, Issue 1, pp. 13082 - 8
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2013, Volume 163, Issue 5, pp. 621 - 630
Summary Chronic lymphocytic leukaemia (CLL) is a disease with a highly variable prognosis. The clinical course can however be predicted thanks to prognostic... 
chronic lymphocytic leukaemia | zeta‐associated protein of 70 | B‐cell receptor | nuclear factor‐κB | Chronic lymphocytic leukaemia | Zeta-associated protein of 70 | B-cell receptor | Nuclear factor-κB | zeta-associated protein of 70 | nuclear factor-B | MESSENGER-RNA EXPRESSION | MUTATION STATUS | ANTIGEN-RECEPTOR | THERAPEUTIC TARGET | GENE-EXPRESSION | CD38 EXPRESSION | ZAP-70 EXPRESSION | PROGNOSTIC MARKERS | CELL-RECEPTOR | HEMATOLOGY | DISEASE PROGRESSION | Interleukin-8 - genetics | Transcription Factor RelA - physiology | Prognosis | Humans | Middle Aged | Neoplasm Proteins - physiology | Transcriptome | ZAP-70 Protein-Tyrosine Kinase - biosynthesis | Male | NF-kappa B - metabolism | Interleukin-1beta - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Immunoglobulin M - immunology | Recombinant Fusion Proteins - metabolism | I-kappa B Kinase - physiology | Quinoxalines - pharmacology | Interleukins - genetics | I-kappa B Kinase - antagonists & inhibitors | Adult | Female | Interleukin-1beta - biosynthesis | Interleukins - biosynthesis | Tumor Cells, Cultured | Neoplasm Proteins - genetics | Calcium Signaling | Interleukin-6 - genetics | Interleukin-8 - biosynthesis | Jurkat Cells | Neoplasm Proteins - biosynthesis | RNA, Messenger - genetics | ZAP-70 Protein-Tyrosine Kinase - physiology | ZAP-70 Protein-Tyrosine Kinase - genetics | Electroporation | Imidazoles - pharmacology | Gene Expression Regulation, Leukemic | Receptors, Antigen, B-Cell - immunology | Interleukin-6 - biosynthesis | Immunoglobulin Variable Region - genetics | Aged | Immunoglobulin Heavy Chains - genetics
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 02/2016, Volume 101, Issue 2, pp. e63 - e65
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2017, Volume 23, Issue 24, pp. 7498 - 7511
Purpose: Daratumumab treatment results in a marked reduction of CD38 expression on multiple myeloma cells. The aim of this study was to investigate the... 
B-CELLS | TROGOCYTOSIS | DEXAMETHASONE | PHAGOCYTOSIS | MONOTHERAPY | NK CELLS | REGULATORY CELLS | ONCOLOGY | LENALIDOMIDE | RESISTANCE | MULTIPLE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Multiple Myeloma - immunology | Monocytes - immunology | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Granulocytes - drug effects | ADP-ribosyl Cyclase 1 - immunology | Killer Cells, Natural - immunology | Female | Gene Expression Regulation, Neoplastic - drug effects | Thalidomide - adverse effects | Dexamethasone - administration & dosage | ADP-ribosyl Cyclase 1 - genetics | Lenalidomide | T-Lymphocytes | Gene Expression Regulation, Neoplastic - immunology | Thalidomide - administration & dosage | Monocytes - drug effects | B-Lymphocytes - immunology | Antibodies, Monoclonal - administration & dosage | Cell Line, Tumor | Aged | Granulocytes - immunology | Multiple Myeloma - genetics | Plasma | Multiple myeloma | Clinical trials | Effector cells | Lymphocytes T | Proteins | Infusion | Reduction | Killer cells | Granulocytes | Lymphocytes | CD38 antigen | Natural killer cells | CD56 antigen | Immune system | Dexamethasone | CD49d antigen | Patients | Membrane proteins | Monocytes | Lymphocytes B | Experimental design | Plasma membranes | Leukocytes (granulocytic) | Cancer | CD38 | multiple myeloma | antibodies | daratumumab | immunotherapy
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 01/2019, Volume 96, Issue 1, pp. 39 - 45
Journal Article
Immunology and Cell Biology, ISSN 0818-9641, 10/2019, Volume 97, Issue 9, pp. 826 - 839
A B cell culture system using BAFF, IL‐4 and IL‐21 was recently developed that generates B cells with phenotypic and functional characteristics of... 
CD40L | IL‐4 | iGB cell | IL‐21 | BCL6 | germinal centre
Journal Article
by Li, Q and Wu, CY and Liu, ZL and Zhang, HQ and Du, YN and Liu, YX and Song, KY and Shi, QF and Li, R
JOURNAL OF IMMUNOLOGY RESEARCH, ISSN 2314-8861, 2019
Gram-negative bacterial sepsis accounts for up to 50% worldwide sepsis that causes hospital mortality. Acute kidney injury (AKI), a common complication of... 
GAMMA | ACTIVATION | INHIBITION | INNATE IMMUNE-RESPONSES | KILLER T-CELLS | INJURY | ENDOTOXEMIA | CD38 | CASCADE | IMMUNOLOGY | NF-KAPPA-B
Journal Article
Journal Article